7XN-13771-79781
3 vaccinations
4 coded responses
29 check-ins
4 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 51-55
- ZIP prefix
- 021 / MA
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- Native Hawaiian or other Pacific Islander
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-17
Registered in v-safe
- 2021-01-17
- 2021-01-18
- 2021-01-19
-
2021-01-21
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: You have a flaw in your survey. If you check nineyoure not allowed to enter other symptoms. Some slight clotting. I have a clotting disorder that usually presents with infection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-29
- 2021-02-05
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-16
- 2021-02-23
- 2021-03-04
- 2021-03-09
- 2021-03-16
-
2021-03-23
Survey response — day 42, dose 2MedDRA: Viral infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: He was like Im fighting off some virus. Also my monos were elevatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-11
- 2021-08-10
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-04
- 2021-10-06
- 2021-10-07
- 2021-10-08
-
2021-10-15
Survey response — day 14, dose 3MedDRA: Cough, Dyspnoea, Fatigue — Feeling: PoorFree text: Fatigue, shortness of breath, cough. It had started before the vaccine but have decided to go ahead and start reporting it since it hasn't seem to go awayMedDRA releases: 2024-11 · check-in free text available
- 2021-10-22
- 2021-10-29
- 2021-11-07
- 2021-11-14
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Low level cold likeMedDRA releases: 2024-11 · check-in free text available
- 2022-03-07
- 2022-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): You have a flaw in your survey. If you check nineyoure not allowed to enter other symptoms. Some slight clotting. I have a clotting disorder that usually presents with infection.
Release 6 — day 42, dose 2
Symptoms: He was like Im fighting off some virus. Also my monos were elevated
Release 10 — day 14, dose 3
Symptoms: Fatigue, shortness of breath, cough. It had started before the vaccine but have decided to go ahead and start reporting it since it hasn't seem to go away
Release 10 — 3 months, dose 3
Symptoms: Low level cold like
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Viral infection | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release